As the binding receptors CXCR1 and CXCR2 are expressed on myeloid derived cells and carcinoma cells [74, 75], CXCL1 expression in CAFs may serve to regulate paracrine signaling interactions with immune cells and cancer cells to promote chemo-resistance and tumor progression. The gene discussed is CXCR1; the disease is carcinoma.